Bone Marrow MSC Derived Extracellular Vesicles for Moderate-to-Severe ARDS: Phase III Trial
Acute Respiratory Distress Syndrome · ARDS
Enrolment: 970 · Results not recorded
Loading the evidence…
Biologic
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
Acute Respiratory Distress Syndrome · ARDS
Enrolment: 970 · Results not recorded
Covid-19
Enrolment: 60 · Results not recorded
Respiratory Distress Syndrome, Adult
Enrolment: 10 · Results not recorded
COVID · Respiratory Distress Syndrome
Enrolment: 100 · Results not recorded
Covid19 · ARDS
Enrolment: 0 · Results not recorded
COVID-19 · Adult Respiratory Distress Syndrome
Enrolment: 26 · Results not recorded
Covid19 · Acute Respiratory Distress Syndrome
Enrolment: 14 · Results not recorded
Acute Respiratory Distress Syndrome
Enrolment: 24 · Results not recorded
Acute Respiratory Distress Syndrome
Enrolment: 26 · Results not recorded
COVID-19 Acute Respiratory Distress Syndrome
Enrolment: 1 · Results not recorded
1 studies reported at therapy level; 1 evidence entries itemised.
Model: Endotoxaemia-induced acute lung injury as a murine model of acute respiratory distress syndrome
Minimally manipulated and preactivated human mesenchymal stem cells reduced lung injury score, pulmonary oedema and bronchoalveolar inflammatory cells and cytokines more effectively than conventionally expanded or non-activated cells.
Extraction: extract · Supplied extraction confidence: 0.6. Machine-extracted fields require source verification.